- Release Date: 18/03/25 10:58
- Summary: FDA Approves Cambium Bio's Potency Assay Strategy for Elate
- Price Sensitive: No
- Download Document 77.51KB
Ann: FDA Approves Cambium Bio's Potency Assay Strategy for Elate
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.055(20.8%) |
Mkt cap ! $5.850M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 32.0¢ | 28.5¢ | $14.12K | 47.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56261 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 3987 | 2 |
View Market Depth
| Last trade - 15.33pm 28/07/2025 (20 minute delay) ? |
| CMB (ASX) Chart |